FOXMEYER ACQUISITION OF SCRIP CARD SMALL BUSINESS PBM
Executive Summary
FOXMEYER ACQUISITION OF SCRIP CARD SMALL BUSINESS PBM April 26 "more than doubles" FoxMeyer's prescription benefits management (PBM) revenues, President and Chief Operating Officer Thomas Anderson said. "This is obviously a very important market," Anderson commented, and "we expect it to grow in importance as health care reforms are implemented "since over 70% of U.S. companies employ 100 people or fewer.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth